Glaucoma is a complex genetic optic disease characterized by a range of optic neuropathies. There are many subtypes of glaucoma but primary open-angle glaucoma (POAG) associated with elevated intraocular pressure (IOP) is the most prevalent form. Based on the age of diagnosis, POAG is categorized as early-onset POAG or juvenile open-angle glaucoma (JOAG) diagnosed between 10 and 35 years and adult-onset POAG (APOAG) diagnosed in the fifth or sixth decade of life. Employing genetic tools like genome wide linkage analysis, association studies, mutation analysis, microarray expression analysis and serial analysis of gene expression at least 26 genetic loci have been identified for POAG but only three causative genes (Myocilin, Optineurin and WDR36) have been discovered till date. Sequence alterations in these genes result in or increase the likelihood of getting this disease than normal subjects. Although currently 5% of the POAG cases are linked to mutations in these three genes, more than 32 genes are identified to be associated with POAG. Like many other complex diseases gene environment interaction plays a pivotal role in the pathogenesis of POAG also. Lifestyle modifications, quality of diet, level of exercise and oxidative stress are the major risk factors influencing the severity and likelihood of POAG. Intense studies are required to find new genes and genetic defects related to POAG and the role of environment on the POAG pathogenesis. These initiatives can give new horizons to the diagnosis and clinical management of POAG.
INTRODUCTION
Glaucoma encompasses a range of ocular disorders involving optic nerve degeneration and if it persists for long it can cause permanent loss of vision. The optic nerve damage involves degeneration of the retinal ganglion cells (RGCs). The impairment of RGCs results in visual field loss. Glaucoma is the second largest cause of blindness worldwide affecting 70 million people (Quigley et al, 1996) . Estimation says that there were 60.5 million people with primary glaucoma in 2010 and there will be 79.6 million by 2020 and which will result in blindness in 11.2 million people by 2020 (Quigley and Broman 2006) . Classification of glaucoma is very ambiguous but it can be classified as primary vs secondary according to etiology, as open angle vs closed angle according to anatomy of the anterior chamber and as infantile vs juvenile vs adult glaucoma based on time of onset. Generally, glaucoma is classified into three major groups: (i) Primary open-angle glaucoma (POAG); (ii) primary acute closed-angle glaucoma; and (iii) primary congenital glaucoma. Among these subtypes, POAG is the most common form of the glaucoma (Quigley et al, 1993) .
Primary open-angle glaucoma (POAG) shares a major role in causing blindness due to glaucoma. It presents severe optic nerve damage and loss of peripheral vision. The POAG patients show a normal anterior segment and are typically associated with elevated intraocular pressure (IOP) (Ray et al, 2003) . Depending upon the age of onset POAG is classified into juvenile-onset POAG or JOAG and adult-onset POAG or APOAG. Juvenile-onset open-angle glaucoma (JOAG) is a type of POAG having an early age of onset developing before the age of 35 marked by severe increase in intraocular pressure, it follows an autosomal dominant pattern of inheritance (Wiggs et al, 1995) . JOAG patients present progressive optic neuropathy along with gradual vision field loss but the affected eye of the patient has a normal anterior chamber (Raymond et al, 1997) . POAG patients often show elevated intraocular pressure (IOP) above 22 mm Hg. But about one-third of the POAG patients have normal IOP and are categorized as normal tension glaucoma (NTG) (Shields MB, 2008) . Both the forms of glaucoma involve optic nerve degeneration but the detailed mechanism is unknown. The precise genetics of glaucoma is not clearly established but it is likely to be a heterogenous disorder involving interaction of many genes and environmental factors (Hany et 
Mutational Analysis
Mutational analysis is mainly based on the candidate gene studies. In this approach, genes having established functional importance in the pathogenesis of the disease are selected. Normal polymerase chain reaction (PCR) is done to amplify the gene and then the purified PCR products are sequenced and screened for mutations in patients. Mutation analysis is a direct approach to find pathogenic sequence alterations but in case of glaucoma this approach has its limitations as in most cases of glaucoma the mutations found in the patients are not associated with the glaucoma pathogenesis. The major drawback of this strategy is it requires prior information about the candidate genes and for disease like glaucoma in which the pathophysiology is less understood, mutation analysis is less efficient in establishing the genetic basis of the disease. So, in diseases like glaucoma where the genetic basis still is ambiguous, genome wide studies is more useful to find new genes linked to glaucoma. Genome-wide studies employ large number of unrelated cases and scans for the presence of markers associated with the disease. Genome-wide studies basically include two genetic tools namely, genome-wide linkage analysis and genome-wide association studies.
Genome-wide Linkage Analysis
Genome-wide linkage analysis is used to identify the genetic determinants for many diseases. This approach is advantageous because it is a genome-wide scan for genetic factors. Linkage analysis does not require a prior knowledge of the genes or risk alleles associated with the disease. In genome-wide linkage analysis, the different genes causing the disease are localized in the genome using the genetic markers that segregate with the disease in the relatives within a family. Using this approach, only the first gene for POAG was identified and mapped by various groups (Sheffield et al, 1993; Stone et al, 1997; Mengkegale et al, 2008) . However, linkage analysis is inefficient in the studies of diseases involving multiple genetic alleles (Risch and Merikangas, 1996) . Environmental factors influencing the phenotypes can affect genetic traits and hence affect the results of linkage analysis (Lander and Botstein, 1989) . So, to overcome the limitations of genome-wide linkage analysis nowadays single nucleotide polymorphisms (SNPs) are used in genome-wide association studies to identify responsible genes for various complex diseases.
Genome-wide Association Studies (GWAS)
In genome-wide association studies, most of the genes of different individuals are examined to see the variations in the genes from individual to individual. These variations are then associated with different traits or diseases. This technique employs genotyping of SNPs in a group of cases and control subjects. GWAS has been proved pivotal in finding genes for many complex diseases. Over 50 disease-associated loci have been identified using GWAS (Hirschhorn and 
Expression Profiling
Expression profiling is used to measure the levels of expression of the genes (whole genome). Microarray gene expression profiling and serial analysis of gene expression (SAGE) are the two major tools employed in this approach (Horan et al, 2009; Mocellin et al, 2007) .
Microarray Gene Expression Studies
Instead of studying one gene at a time, microarray gene expression study analyses many genes at a time by the use of gene chips. Microarray gene expression profiling uses predesigned probes for desired genes. The level of gene expression is set relative to a reference sample (Mocellin et al, 2007) . This high throughput technique has opened numerous ways to explore the genetics of POAG.
Serial Analysis of Gene Expression (SAGE)
SAGE presents several advantages over traditional microarrays. In this method, mRNA transcripts are directly measured and a nonbiased gene expression profile is obtained without the need of a reference sample (Horan et al, 2009 ). The major attraction of SAGE is its high sensitivity to identify even fine variations in expression levels and also this technique detects novel transcripts without prior knowledge of gene sequence. This technique has proved its importance in determining the expression profiles of many genetic diseases, including cardiovascular disease, diabetes, Down's syndrome and Parkinson disease.
Genetic Loci for POAG
In spite of the advances in the field of molecular genetics and high throughput genome sequencing till date only 15 chromosomal loci have been identified for POAG. All these data come from the family studies employing linkage analysis tools. Out of the 15 identified loci for POAG, only five loci have been found to be related to JOAG and the rest 10 loci are linked to APOAG. Although the first genetic loci associated with POAG was identified by Sheffield et al in the year 1993, till date only four genes have been identified to be directly involved in the pathogenesis of POAG in these loci.
Genetic Loci and Identified Genes for JOAG
JOAG is a type of POAG having an early age of onset developing before the age of 35 marked by severe increase in intraocular pressure, it follows an autosomal dominant pattern of inheritance (Wiggs et al, 1995) . Of the 15 identified POAG genetic loci, five (GLC1A, GLC1J, GLC1K, GLC1M and GLC1N) are found to be associated with JOAG. Myocilin (MYOC) is the only causative gene identified in the GLC1A locus (Stone et al, 1997 ) that is involved in the pathogenesis of JOAG.
GLC1A
GLC1A locus was identified by Sheffield et al in the year 1993. They studied a 33 member family having 22 affected members. By the use of linkage analysis employing short tandem repeat markers they could map the disease causing gene to chromosomal location 1q21-q31. This work was carried forward by Stone et al and in 1997 their group for the first time identified myocilin (MYOC) as a glaucoma causing gene in this locus.
Myocilin (MYOC) (Fig. 2)
Heterozygous mutations were found in the gene encoding for trabecular meshwork induced glucocorticoid response protein (TIGR) now renamed as myocilin (MYOC) in JOAG patients. MYOC contains three exons and it codes for a glycoprotein myocilin. Myocilin is expressed in many tissues including trabecular meshwork and ciliary body of the eye (Resch et al, 2009 ). Myocilin protein is 504 amino acids long and the predicted molecular weight is 55 to 57 kDa (Fig. 1 ). An olfactomedin domain is encoded by the distal part of the gene and the proximal segment of the gene encodes for a leucine zipper protein-binding motif helping myocilin to form dimmers and multimers ; Resch ZT and Fautsch MP 2009). (Yen et al, 2007) . Many studies have established mutation-specific phenotypes of this gene. TYR437HIS and ILE477ASN mutations are very strongly associated with JOAG. The mean maximum IOP in patients presenting TYR437HIS mutation was found to be 44 mm Hg and those showing ILE477ASN mutations had a mean maximum IOP of 40 mm Hg (Alward et al, 1998) . Another prevalent mutation in the MYOC gene is GLN368STOP, but it is associated with APOAG. Patients having this mutation show a mean maximum IOP of 30 mm Hg (Alward et al, 1998) . Many MYOC mutations are specific to particular ethnic groups and geographic areas but population studies in the African-American and Caucasians of the United States, Canada, Europe, South America and Australia show GLN368STOP mutation to exist in all of these observed populations. Many MYOC mutations are associated with both JOAG and APOAG. The LYS423GLU mutation was found to be associated with JOAG in some family members and APOAG in some other members (Morissette et al, 1998) . 
GLC1K
By genome-wide linkage and haplotype analysis of five families, Wiggs et al could find GLC1K locus linked to JOAG (Wiggs et al, 2004 ). This locus was mapped to 20p12 chromosomal location. No glaucomatous gene has been associated to this locus till date.
GLC1M
Pang et al in 2006 identified a locus associated with JOAG (GLC1M) and mapped it to chromosomal location 5q22.1. Their study was conducted on a five generation Filipino JOAG family. No causative gene in this locus is still identified.
GLC1N
A genome-wide study of a three generation Chinese JOAG family by Wang et al in 2006 reviled a genetic locus associated with JOAG (GLC1N) to chromosomal location 15q22-q24. To date, no causative gene is identified in this locus.
Genetic Loci and Identified Genes for APOAG and NTG
APOAG is a form of POAG diagnosed after 50 years of age and has a characteristic feature of elevated IOP in the eye with a normal anterior chamber. APOAG is the commonest form of glaucoma (Quigley et al, 2006 ) but there exists a subset of APOAG too which is not associated with elevated IOP and is called normal tension glaucoma (NTG). APOAG mostly deviates from the simple Mendelian inheritance pattern but till date out of the 15 identified POAG loci at least 10 genetic loci have been assigned to APOAG.
GLC1A
As already described GLC1A locus is linked to JOAG, it is also associated with APOAG. The causative glaucoma gene, i.e MYOC identified in this locus harbors population-specific mutations. The GLN368STOP mutation is found in almost all the studied POAG populations. The patients having this mutation in their MYOC gene are diagnosed to have glaucoma above 50 years of age (Resch et al, 2009 ). So, MYOC is involved in both JOAG and APOAG.
GLC1E
Sarfarazi et al in 1998 reported the localization of GLC1E locus to 10p15-p14 region of the chromosome on the basis of their study on a 39 member British APOAG family having 16 affected persons most of them presenting with NTG. The causative gene in this locus was found by Rezaie et al in 2002 in their study of 55 families having APOAG and this gene was named as OPTN (optineurin). Most of the affected members in this family were having NTG. This group also found heterozygous mutation (GLU50LYS) in the OPTN gene in a British family and eight other NTG-affected families. Mutation studies in various populations have shown that up to 1.5% of NTG cases present with sequence alterations in this gene (Alward et al, 2003) . There are some other mutations reported in this gene also but surprisingly some of these mutations cause glaucoma in a particular population group but not in others. (Sahlender et al, 2005) . Optineurin is involved in Nf-kB signaling pathway (Nagabhushana et al, 2011) . Optineurin is expressed in nonpigmented ciliary epithelium, retina, trabecular meshwork and brain cells, and it is speculated to have a role in neuroprotection (Rezaie et al, 2002) . De Marco et al in 2006 showed that optineurin plays a significant role in the protection of cells from oxidative stress-induced apoptosis. They overexpressed the wild-type protein in the cell cultures and observed an enhanced protection of these cells against oxidative stress-induced apoptosis but this result was not observed with the overexpression of the mutated optineurin protein. Transgenic mice harboring GLU50LYS mutation in optineurin gene showed apoptosis in the retinal ganglion cells. These studies also demonstrated that optineurin-related glaucoma may result due to improper interaction of optineurin and Rab8 and its negative effects on protein transport (Chi et al, 2010 ).
GLC1F
A genome-wide study of a four-generation POAG family having 10 POAG-affected members by Wirtz et al in 1999 established GLC1F as a locus associated with APOAG and located it to chromosomal segment 7q35-q36. Till date no causative gene is found to be linked to this locus.
GLC1B
Linkage study using two points and haplotype analysis of affected and normal meioses in six families by Stoilova et al in the year 1996 demonstrated that GLC1B located at 2cen-q13 region is associated with APOAG but still a causative gene is to be identified in this locus.
GLC1C
In their study of a POAG affected American family, Wirtz et al in 1997 established 3q21-q24 region of the chromosome to be associated with APOAG and this segment of the chromosome was named as GLC1C. There is no glaucoma-causing gene still established in this region.
GLC1D
Linkage and haplotype analysis of a three-generation family having 20 APOAG-affected subjects proved GLC1D locus situated at 8q23 to be associated with APOAG . Still no causative gene is identified in this locus.
GLC1H
Suriyapperuma et al in 2007 established GLC1H segment located at 2p15-p16 to be associated with APOAG. They did a genome-wide scan and linkage analysis of this 119 member family to establish GLC1H to be linked to APOAG. No glaucoma-causative gene is still found in this locus.
GLC1I
GLC1I having chromosomal location 15q11-q13 was identified to be associated with APOAG by Allingham et al in the year 2005 as a result of their genome-wide study of 86 families. Till date no causative gene is identified in this locus.
GLC1L
Baird et al in the year 2005 identified GLC1L having chromosomal location 3p22-q21 to be associated with APOAG by their study on a APOAG-affected family. No glaucoma causing gene is still identified in this locus.
GLC1G
Monemi et al in the year 2005 reported GLC1G locus located at 5q22.1 to be associated with APOAG and identified a causative gene in this locus. They did mutation analysis of seven genes of this locus and found only one significant pathogenic mutation in the WD repeat containing (WDR36) gene. They found four mutations (N355S, A449T, R529Q and D658G) in this gene in 17 subjects (11 having elevated IOP and 6 having normal IOP). Miyazawa et al in 2007 from their studies on Japanese POAG-affected families-documented that mutations in WDR36 gene do not directly cause POAG rather these altered forms of this gene increase the susceptibility and severity of POAG. It is being reported that some mutated forms of this gene increases the apoptosis rate of retinal ganglion cells (Chi et al, 2010) . 
Other Loci for POAG
Apart from the 15 genetic loci mentioned earlier for POAG, there are many other chromosomal regions found associated with this form of glaucoma. Linkage analysis of a large Australian POAG family gave evidence of 10q22 and 1p32 chromosomal segment to be associated with POAG (Charlesworth et al, 2005) . Likewise, many other chromosomal regions as 2p15-16 (Lin et al, 2008),  2p14, 19q12, 17q25.1-17q25.3, 14q11.1-14q11.2, 14q21.1-q21.3 and 17p13 (Wiggs et al, 2000) , 10p12.33-p12.1 and 2q33.1-q33.3 (Namesure et al, 2003) are found to be associated with POAG on the basis of family studies.
POAG: Complex Disease
POAG is a complex genetic disease being affected by many genes. Although genome-wide association studies and linkage analysis of families have established some causative genes for glaucoma but these known glaucoma causing genes account for only less than 5% of POAG (as reviewed by Fingert JH 2011) . Since POAG is a complex disease, it would not be wrong in speculating that POAG pathogenesis may be an integrated effect of several genes and gene environment interactions. GWAS has proved pivotal in determining the risk factors for many ocular diseases so in recent past many groups have well utilized this powerful genetic tool to unfold the genetic risk factors for POAG and identified 32 genes associated with POAG (Reviewd by Fuse N in 2010 and Fingert JH in 2011). These genes increase the chances of development and intensity of the pathogenesis of POAG.
Oxidative Stress, Environmental and Lifestyle Parameters: Role in Glaucoma
POAG being a complex genetic disease is related to environmental factors like lifestyle modifications, quality of diet, exercise, oxidative stress, smoking and alcohol consumption (Fig. 1) . As described before, POAG is a heterogeneous disease, same mutation results in glaucoma in certain population, but not in the other.
The prevalence of POAG also is reported to be varied and differs by two orders of magnitude with lowest frequencies among Eskimos inhabiting Alaska (Arkell et al, 1987) and highest frequency in the Africans inhabiting Caribbean (Leske et al, 1994) . This difference in the prevalence of POAG among different ethnic groups is suggestive of the role of environmental factors and lifestyle modification in the developing risk of POAG. IOP is established to be a quantitative genetic trait (Duggal et al, 2007) . Increased IOP is a characteristic feature of POAG. So, factors associated with increased IOP can also be linked to POAG. Certain lifestyle activities as coffee or tea consumption (Avisar et al, 2002) , playing high-wind instruments (Schuman et al, 2000) , specific yoga positions (Baskaran et al, 2006) , wearing tight neck ties (Tatly et al, 2005) , and weightlifting have been associated with elevated IOP (Vieira et al, 2006) . Exercise lowers IOP, but the effect of exercise on IOP depends upon the intensity of exercise (Qureshi et al, 1996) .
In a study by Fan et al in the year 2004 on Chinese POAG patients, they found interesting correlations between risk of POAG and environmental factors. They reported that a person having a family history of POAG is 20 times more susceptible to POAG than a person without a family history. Same study also established that person having normal blood pressure is 3.6 times less susceptible to POAG than hypertensive persons. Fan et al also found that 11 times more at risk for POAG than nonsmokers. This group has also documented alcohol consumption as a protective factor against POAG. They found that nondrinkers are 97.2% more susceptible to POAG than regular drinkers. They have speculated that small amounts of alcohol cause dilation of vessels facilitating aqueous outflow and hence can reduce IOP and consequently reducing the risk of POAG.
Dietary intake of fruits, vegetables, carotenoids, vitamin E and vitamin C do not decrease the likelihood of POAG (Kang et al, 2003) but fat intake has shown some protective effect against POAG. A diet rich in ω-6: ω-3 ratio was found to lower the risk for POAG but no correlation was found for total dietary intake of fats with POAG. Some studies in animals have proved ω-3 to be protective against POAG (Kang et al, 2003; Nguyen et al, 2007) . Animal studies have established the role of reproductive hormones like estrogen in protection of retinal ganglion cells from apoptosis (Nakazawa et al, 2006) . Further studies conducted to establish relationship between reproductive hormones and risk for glaucoma prove postmenopausal hormone to be associated with lowered IOP and increased blood supply to the retinal ganglion cells (Affinito et al, 2003) . Oxidative stress has been established as a major risk factor in many diseases. A study by Gherghel et (Fig. 3) .
DISCUSSION
Glaucoma is a heterogeneous, complex genetic disorder and POAG is the most prevalent form of this blinding optic disease. Since, the damage caused to the eye by this disease is irreversible, POAG has drawn much attention of the researchers worldwide. Although various genetic tools like genome-wide linkage analysis, genome-wide association studies and mutation analysis have been used to explore the genetic basis of POAG, till date only 26 genetic loci have been identified to be associated with POAG and only 3 genes (myocilin, optineurin and WDR36) have been found to be directly involved in the pathogenesis of this optic neuropathy. Sequence alterations in 
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these genes are found to be responsible for POAG in certain cases. Mutation in these genes account for only 5% cases of POAG and the molecular mechanisms underlying the role of these identified genes and the respective pathogenic mutations in the progression of this disease is still ambiguous. Phenotypic expression of the sequence alterations in these genes is not constant as same mutation in a gene causes POAG in one group and not in the other. POAG is not a single gene disorder. The pathogenesis of POAG involves the interplay of many genes and gene environment interactions. Apart from the 3 causative genes, 32 other genes have been identified to be risk factors for POAG. These genes are not directly involved in the pathogenesis of POAG but enhance the risk of development and severity of the disease. Many environmental factors, like lifestyle modifications, quality of diet, exercise, oxidative stress, smoking and alcohol consumption have been linked to POAG and reported by various groups. There is no clear-cut evidence of the correlation of total dietary intake of carotenoids, vitamin C, vitamin E and fat with IOP levels and POAG but a diet high in ω-6: ω-3 ratio is found to lower the risk for POAG. Postmenopausal hormones, like estrogens and estrogen analogues, have been proved to be protective against IOP elevation and POAG. Smoking and consumption of coffee increases the risk of POAG but surprisingly moderate alcohol intake gives protection against POAG by a mechanism that increases the blood flow to the optic nerve. So, not only genetic factors but also the environmental factors associated with POAG should be evaluated for a better understanding of the pathogenesis of POAG. Molecular techniques, like microarray gene expression analysis and serial analysis of gene expression (SAGE), should promptly be used to know the changes in the expression profile of the POAG patients and discover more causative genes.
CONCLUSION AND FUTURE PROSPECTS
POAG is a complex genetic disease only a small proportion following Mendelian pattern of inheritance. Wise use of genetic tools like genome-wide association and linkage studies, mutation screening, microarray gene expression profiling and serial analysis of gene expression will increase our knowledge of the genetics of POAG and unravel many more unidentified POAG loci and genes. Once the genetics of POAG is well established, genetic screening methods like mutation analysis, single nucleotide polymorphisms (SNPs) and microarray gene expression chips can be used to predict the chances of disease development and severity. Use of established POAG SNPs as genetic markers as diagnostic tools can broaden the field of pharmacogenomics and help in designing personalized medicines for POAG. The studies related to POAG so far are confined to discover new glaucomatous loci and genes, but equal efforts should be given in understanding the interaction of the established genes and loci with others. Although the genetics of POAG has progressed but still the role of environmental factors is not well established. Association and multivariate studies will unfold the various environmental factors associated with POAG which will ultimately help the clinicians to predict the likelihood of POAG on the basis of exposure of the patient to the various high-risk environmental factors.
